Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Therapeutic Advances in Respiratory Disease|June 17, 2017
Evaluation and management approaches for scleroderma lung diseaseSara R Schoenfeld, Flavia V CastelinoRheumatic Diseases Clinics of North America|April 4, 2015
Interstitial lung disease in sclerodermaSara R Schoenfeld, Flavia V CastelinoCurrent Opinion in Rheumatology|July 20, 2012
Lipids and eicosanoids in fibrosis: emerging targets for therapyFlavia V CastelinoArthritis Research & Therapy|August 26, 2010
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and managementFlavia V Castelino, John VargaClinical and Experimental Rheumatology|August 30, 2024
Potential of phosphodiesterase 4B inhibitors in the treatment of interstitial lung disease associated with autoimmune diseasesFlavia V Castelino, Ayodeji AdegunsoyeExpert Review of Clinical Immunology|October 31, 2013
Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug developmentFlavia V Castelino, John VargaACR Open Rheumatology|March 29, 2021
Detection and Management of Interstitial Lung Diseases Associated With Connective Tissue DiseasesFlavia V Castelino, Teng MouaCurrent Opinion in Rheumatology|September 6, 2014
Emerging cellular and molecular targets in fibrosis: implications for scleroderma pathogenesis and targeted therapyFlavia V Castelino, John VargaCurrent Opinion in Rheumatology|September 21, 2018
Recent progress in systemic sclerosis-interstitial lung diseaseFlavia V Castelino, Paul F DellaripaRheumatology (Oxford, England)|August 6, 2010
The impact of rheumatological evaluation in the management of patients with interstitial lung diseaseFlavia V Castelino, Hilary Goldberg, Paul F DellaripaPageof 6